Biodegradable xylitol-based elastomers: in vivo behavior and biocompatibility

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Regenerative Medicine

Background:

• Biodegradable elastomers are crucial for medical applications, requiring materials with predictable degradation and biocompatibility.
• Poly(xylitol sebacate) (PXS) elastomers, synthesized via polycondensation, represent a novel class of biodegradable materials.
• Understanding the in vivo performance of PXS is essential for their clinical translation.

Purpose of the Study:

• To evaluate the in vivo behavior and degradation characteristics of novel poly(xylitol sebacate) (PXS) elastomers.
• To compare the biocompatibility and structural integrity of PXS elastomers with a standard biodegradable polymer, poly(L-lactic-co-glycolic acid) (PLGA).

Main Methods:

• Synthesis and characterization of four different PXS elastomer formulations.
• In vivo implantation studies to assess degradation, structural integrity, and biocompatibility.
• Comparative analysis against PLGA implants.

Main Results:

• PXS elastomers maintained high structural integrity and form stability throughout the degradation process.
• The in vivo half-life of PXS elastomers varied significantly, ranging from approximately 3 to 52 weeks.
• PXS elastomers demonstrated superior biocompatibility compared to PLGA implants in vivo.

Conclusions:

• Poly(xylitol sebacate) elastomers offer promising biodegradable material options with excellent in vivo stability and biocompatibility.
• The tunable degradation profile of PXS elastomers suggests potential for diverse biomedical applications.
• PXS elastomers represent a viable alternative to existing biodegradable polymers like PLGA for tissue engineering and medical devices.